[1] DEGAM-Leitlinie Nr. 2: Müdigkeit - Update 2011: http://leitlinien.degam.de/index.php?id=72

[2] ICD-10-GM Version 2012 http://www.dimdi.de/static/de/klassi/diagnosen/icd10/htmlgm2012/block-g90-g99.htm

[3] ICD-10-GM Version 2012 Kapitel V Psychische und Verhaltensstörungen (F00-F99)

http://www.dimdi.de/static/de/klassi/diagnosen/icd10/htmlgm2012/block-f40-f48.htm

[4] Chaudhuri A. Chronic fatigue syndrome and myalgic encephalomyelitis. Lancet 2002; 359: 1698-99

[5] Neuro Endocrinol Lett. 2009;30(3):284-99. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Twisk FN, Maes M. http://www.ncbi.nlm.nih.gov/pubmed/19855350

[6] Clin Rheumatol. 2011 Mar;30(3):381-9. Epub 2011 Jan 15. Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up. Núñez M, Fernández-Solà J, Nuñez E, Fernández-Huerta JM, Godás-Sieso T, Gomez-Gil E. http://www.ncbi.nlm.nih.gov/pubmed?term=Nunez%2C%20Clin%20Rheumatol%202011

[7] Cancer. 2005 Aug 15;104(4):788-93. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Meyers CA, Albitar M, Estey E.

http://www.ncbi.nlm.nih.gov/pubmed/15973668

[8] Cancer-Related Fatigue: Epidemiology, Pathogenesis, Diagnosis, and Treatment Dtsch Arztebl Int 2012; 109(9): 161-72; DOI: 10.3238/arztebl.2012.0161, DOI: 10.3238/arztebl.2012.0161 Horneber, M; Fischer, I; Dimeo, F; Rüffer, JU; Weis, J http://www.aerzteblatt.de/int/archive/hits?intAutor=Horneber%2C+M

[9] PLoS One. 2011;6(10):e26358. Epub 2011 Oct 19. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H, Mella O.

http://www.ncbi.nlm.nih.gov/pubmed/22039471

[10] Autoimmun Rev. 2009 Feb;8(4):287-91. Epub 2008 Sep 16. Immunological aspects of chronic fatigue syndrome.

Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G.

http://www.ncbi.nlm.nih.gov/pubmed?term=Lorusso.%20Autoimmun%20Rev%202009%20

[11] J Clin Virol. 2006 Dec;37 Suppl 1:S33-8. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C,

Montoya JG. http://www.ncbi.nlm.nih.gov/pubmed?term=Kogelnik%2C%20Clin%20Virology%202006%20

[12] A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome Author(s): A Martin Lerner | Safedin Beqaj Journal: Virus Adaptation and Treatment ISSN 1179-1624 Volume: 2011; Issue: default; Start page: 19; Date: 2011

http://journaldatabase.org/articles/paradigm_linking_herpesvirus.html

[13] Brain Behav Immun. 2011 Nov;25(8):1544-7. Epub 2011 Apr 28. Increased HDAC in association with decreased plasma cortisol in older adults with chronic fatigue syndrome. Jason L, Sorenson M, Sebally K, Alkazemi D, Lerch A, Porter N, Kubow S. http://www.ncbi.nlm.nih.gov/pubmed?term=Jason%2C%20Brain%20Behav%20Imm%202011%20